Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Prostate cancer screenings slash the risk of dying from the disease in the following decades, according to new research. The screening measures the amount of prostate-specific antigen (PSA) in men’s ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.

VolitionRx Limited (NYSE MKT: VNRX) today announced that it has initiated a study to assess the feasibility of using the Company’s NuQ ® blood tests to detect prostate cancer. The study is in ...

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found.

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

Maurice Blake says he never knew that one-in-four black men face prostate cancer - double the average.